WEKO3
アイテム
Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors
https://repo.qst.go.jp/records/58564
https://repo.qst.go.jp/records/58564caea8cac-ba63-40ac-9427-fa3332b71bf7
| Item type | 一般雑誌記事 / Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2015-08-14 | |||||
| タイトル | ||||||
| タイトル | Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | article | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Kinuya, Seigo
× Kinuya, Seigo× Yoshinaga, Keiichiro× Higuchi, Tetsuya× Jinguji, Megumi× Kurihara, Hiroaki× Kawamoto, Hiroshi× 絹谷 清剛× 吉永 恵一郎× 樋口 徹也 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Since the 1980s when clinical therapeutic trials were initiated, 131I-MIBG radiotherapy has been used in foreign countries for unresectable neuroendocrine tumors including malignant pheochromocytomas and neuroblastomas. In Japan, 131I-MIBG radiotherapy has not been approved by the Ministry of Health, Labour and Welfare; however, personally imported 131I-MIBG is now available for therapeutic purposes in a limited number of institutions. These updated draft guidelines aim to provide useful information concerning 131I-MIBG radiotherapy, to prevent side effects, and to protect physicians, nurses, other health care professionals, patients and their families from radiation exposure. The committee has also provided appendices on topics such as practical guidance for attending physicians, patient management, and referring physicians. | |||||
| 書誌情報 |
The Japanese Journal of Nuclear Medicine 巻 52, 号 1, p. 1-48, 発行日 2015-02 |
|||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 002-7854 | |||||
